The world is in the middle of a peptide drug revolution. These short chains of amino acids—the building blocks of ...
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Amide Technologies, a biotech that synthesizes challenging peptides, announced today that it has begun commercializing its novel peptide manufacturing platform. The ...
BOSTON--(BUSINESS WIRE)--Mytide Therapeutics, a company transforming peptide manufacturing with predictive analytics and machine learning, has raised $7 million in Series A financing. The round was ...
In an industry often clouded by opaque sourcing and inconsistent quality, Peptide Hubs stands as a beacon of transparency. Every product in the new lineup undergoes a rigorous journey before it ...
BASEL, Switzerland, March 5, 2025 /PRNewswire/ -- Following its 16 July 2024 announcement, CordenPharma is pleased to share significant progress on its growth initiatives with a >€1 billion strategic ...
This collaboration aims to enhance supply chain resilience, improve operational efficiency and accelerate readiness for the rapidly expanding global peptides market. This partnership strengthens LMS ...
With the growing demand for healthy diets and functional foods, plant extracts and plant protein peptides are increasingly ...
Mass spectrometry (MS) has long been a cornerstone of chemical and biological analysis, but in biotech and biomanufacturing, it is now experiencing a renaissance. As drug modalities diversify—peptides ...
Expansion Boosts Solid-Phase Peptide Synthesis Total Reactor Volume to 32,000 Liters in Response to Surging Demand With this announcement, the Changzhou site inaugurated its third peptide plant. The ...
Asahi Kasei Bioprocess America is part of the Asahi Kasei Life Science operating segment, encompassing the organization’s purification, fluid management, biosafety, and biologics development and ...
This Collaboration and Exclusive Licensing Agreement expands the Company's existing portfolio of targeted alpha therapies, led by ADVC001, a first-in-class 212Pb-PSMA radioligand therapy. The ...